newsfilter
← Latest News
GlobeNewswire·

InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding

Targeting neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson'sIdentified two lead cannabinoid analog compounds for in vivo studiesNSERC grant funding supports InMed's collaborative research